Drugs / adipose-derived stromal cells
last change May 2015 re-read 3 minutes ago

adipose-derived stromal cells

Cell therapy

Developed for
osteoarthritis, knee
Investigated by
Fodor, Peter B, M.D. · Plastic Surgery Education and Research Foundation

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02357485 Mar 2014 → May 2015 osteoarthritis, knee Fodor, Peter B, M.D. Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as adipose-derived stromal cells “used autologous adipose-derived stromal cells (ADSC), the stromal vascular fraction (SVF), to treat 8 osteoarthritic (OA) knees in 6 patients” NCT02357485 ↗
Known as ADSC ClinicalTrials.gov intervention name — accepted as the source's own label NCT02357485 ↗
Known as stromal vascular fraction (SVF) “used autologous adipose-derived stromal cells (ADSC), the stromal vascular fraction (SVF), to treat 8 osteoarthritic (OA) knees in 6 patients” NCT02357485 ↗
Modality Cell therapy “autologous adipose-derived stromal cells” NCT02357485 ↗
Route Other “injected directly into the intra-articular space” NCT02357485 ↗